Takeover

Acquirers

Chondrial Therapeutics, Inc.

Targets
1
Filings
2
Median premium
65%
First filing
Mar 6, 2020
Latest filing
Apr 29, 2020

Targets

CompanyTakeover scoreFilingsLatest
LRMRLarimar Therapeutics, Inc.02Apr 29, 2020

Deal filings

FiledCompanyFormPricePremium
Apr 29, 2020LRMRLarimar Therapeutics, Inc.DEFM14A$645.51—
Mar 6, 2020LRMRLarimar Therapeutics, Inc.PREM14A$1.1864.55%